Overview / Abstract: |
Pharmacists play a vital role in the management of patients with heart failure (HF). Navigate through this interactive self-directed, pharmacist-targeted activity designed to optimize your decision-making to apply the most recent clinical trial data and guidance seen in real-world HF practice, particularly in patients with worsening HF and after recent HF hospitalization. Expert perspectives and insights cover guideline-directed medical therapy (GDMT) implementation and additional adjustment therapies to improve patient quality of life, hospitalization rates, and mortality risks in your patients with worsening HF. |
Expiration |
Jun 16, 2024 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
1 Contact Hour |
Accreditation |
ACPE |
Presenters / Authors / Faculty |
Cait E. Kulig, PharmD, HF-Cert B. Andrew Mardis, PharmD, BCCP, BCTXP, BCPS |
Sponsors / Supporters / Grant Providers |
Supported by an independent medical educational grant from Merck & Co., Inc.. |
Keywords / Search Terms |
ACHL Heart failure, HF, cardiology, American Heart Association, AHA, cardiovascular, CE, continuing education, Accreditation Council for Pharmacy Education, ACPE, MOAs, LVAF, SBP, NT-proBNP levels, kidney function, hospital pharmacists, clinical pharmacists, cardiologists, clinical nurse specialist, hospitalists, internists, primary care providers, GDMT, guideline-directed medical therapy, vericiguat, worsening heart failure Free CE CME |